121 related articles for article (PubMed ID: 3066661)
1. Regulation of N-myc expression is a critical event controlling the ability of human neuroblasts to differentiate.
Thiele CJ; Israel MA
Exp Cell Biol; 1988; 56(6):321-33. PubMed ID: 3066661
[No Abstract] [Full Text] [Related]
2. [ALK, a key gene in the pathogenesis of neuroblastoma].
Janoueix-Lerosey I; Delattre O
Med Sci (Paris); 2009 Apr; 25(4):330-2. PubMed ID: 19409178
[No Abstract] [Full Text] [Related]
3. [Pathology of peripheral neuroblastic tumors].
Wang L; He LJ; Shimada H
Zhonghua Bing Li Xue Za Zhi; 2012 Apr; 41(4):283-8. PubMed ID: 22800533
[No Abstract] [Full Text] [Related]
4. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification.
Castle VP; Heidelberger KP; Bromberg J; Ou X; Dole M; Nuñez G
Am J Pathol; 1993 Dec; 143(6):1543-50. PubMed ID: 8256847
[TBL] [Abstract][Full Text] [Related]
5. Detection of n-myc gene amplification in neuroblastoma by comparative, in situ,and real-time polymerase chain reaction.
Melegh Z; Bálint I; Tóth E; Csernák E; Szentirmay Z; Nagy K
Pediatr Pathol Mol Med; 2003; 22(3):213-22. PubMed ID: 12746172
[TBL] [Abstract][Full Text] [Related]
6. Patterns of regulation of nuclear proto-oncogenes MYCN and MYB in retinoic acid treated neuroblastoma cells.
Thiele CJ
Prog Clin Biol Res; 1991; 366():151-6. PubMed ID: 2068135
[No Abstract] [Full Text] [Related]
7. N-myc amplification causes down-modulation of MHC class I antigen expression in neuroblastoma.
Bernards R; Dessain SK; Weinberg RA
Cell; 1986 Dec; 47(5):667-74. PubMed ID: 3096575
[TBL] [Abstract][Full Text] [Related]
8. Low expression of Wnt-5a gene is associated with high-risk neuroblastoma.
Blanc E; Roux GL; Bénard J; Raguénez G
Oncogene; 2005 Feb; 24(7):1277-83. PubMed ID: 15592517
[TBL] [Abstract][Full Text] [Related]
9. Nucleotide sequence of the human N-myc gene.
Stanton LW; Schwab M; Bishop JM
Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1772-6. PubMed ID: 2869488
[TBL] [Abstract][Full Text] [Related]
10. The expression of multiple proto-oncogenes is differentially regulated during retinoic acid induced maturation of human neuroblastoma cell lines.
Thiele CJ; Deutsch LA; Israel MA
Oncogene; 1988 Sep; 3(3):281-8. PubMed ID: 3060792
[TBL] [Abstract][Full Text] [Related]
11. The evolution of clinical molecular genetics. Neuroblastoma as a model tumor.
Israel MA
Am J Pediatr Hematol Oncol; 1986; 8(2):163-72. PubMed ID: 3526938
[TBL] [Abstract][Full Text] [Related]
12. Neuroblastoma: inverse relationship between expression of N-myc and NGF-r.
Christiansen H; Christiansen NM; Wagner F; Altmannsberger M; Lampert F
Oncogene; 1990 Mar; 5(3):437-40. PubMed ID: 2156211
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of c-myc oncogene during NGF-induced differentiation of neuroblastoma cell lines.
Chen J; Liu T; Ross AH
Chin Med Sci J; 1994 Sep; 9(3):152-6. PubMed ID: 7865834
[TBL] [Abstract][Full Text] [Related]
14. [Amplification of N-myc in neuroblastoma: paradigm for clinical use of an oncogene alteration].
Schwab M
Klin Padiatr; 1990; 202(4):197-201. PubMed ID: 2203936
[TBL] [Abstract][Full Text] [Related]
15. Expression of proto-oncogene products during drug-induced differentiation of a neuroblastoma cell line SK-N-DZ.
Matsumoto M; Akiyama T; Miyatake S; Oda Y; Kikuchi H; Hanaoka M; Namba Y
Acta Neuropathol; 1989; 79(2):217-21. PubMed ID: 2480694
[TBL] [Abstract][Full Text] [Related]
16. Network Modeling of microRNA-mRNA Interactions in Neuroblastoma Tumorigenesis Identifies miR-204 as a Direct Inhibitor of MYCN.
Ooi CY; Carter DR; Liu B; Mayoh C; Beckers A; Lalwani A; Nagy Z; De Brouwer S; Decaesteker B; Hung TT; Norris MD; Haber M; Liu T; De Preter K; Speleman F; Cheung BB; Marshall GM
Cancer Res; 2018 Jun; 78(12):3122-3134. PubMed ID: 29610116
[TBL] [Abstract][Full Text] [Related]
17. Wnt-5a gene expression in malignant human neuroblasts.
Blanc E; Goldschneider D; Douc-Rasy S; Bénard J; Raguénez G
Cancer Lett; 2005 Oct; 228(1-2):117-23. PubMed ID: 15925444
[TBL] [Abstract][Full Text] [Related]
18. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
Goto S; Umehara S; Gerbing RB; Stram DO; Brodeur GM; Seeger RC; Lukens JN; Matthay KK; Shimada H
Cancer; 2001 Nov; 92(10):2699-708. PubMed ID: 11745206
[TBL] [Abstract][Full Text] [Related]
19. Molecular pathology of human neuroblastomas.
Brodeur GM
Semin Diagn Pathol; 1994 May; 11(2):118-25. PubMed ID: 7809505
[TBL] [Abstract][Full Text] [Related]
20. Neuroblastoma--clinical applications of molecular parameters.
Brodeur GM
Brain Pathol; 1990 Sep; 1(1):47-54. PubMed ID: 1669693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
